Meiban buys Australia's Planet Innovation to build medtech manufacturing arm

What's the deal? Singapore-based Meiban GroupDealroom has a profile for this one. Try Dealroom → is acquiring Planet Innovation, a Melbourne-founded medtech product developer, via a scheme of arrangement. The deal value was undisclosed. It was announced on November 9, 2026.

Who are they? Meiban is a global contract development and manufacturing organisation specialising in high-volume, precision manufacturing for the medtech sector, with facilities across Singapore and Malaysia. Planet Innovation designs, develops, and manufactures regulated medical devices for clients in Australia and the United States.

Why now? The acquisition follows a strategic alliance struck in 2025, when Meiban took an initial ~19.9% stake in Planet Innovation. The full purchase completes that build-up.

What's the endgame? The two plan to combine their complementary businesses into an integrated contract development and manufacturing organisation serving the global medtech sector. The deal also marks Meiban's entry into the Australian market.

The signal: The transaction fits a wider pattern of buyers using acquisitions to add strategic capabilities and reach new geographies. For Meiban, bolting on Planet Innovation's design and development expertise extends its manufacturing footprint across the medtech supply chain.

Read more: hsfkramer.com

Image credit: Generated with Gemini